CCL2 and Hermansky-Pudlak syndrome: Furthermore, blocking the MCP-1/C-C chemokine receptor type 2 (CCR2) signaling pathway and the epithelial-specific transgenic correction on the HPS-deficiency significantly attenuated bleomycin-induced AT2 cells apoptosis, fibrosis susceptibility, and macrophage activation [95,96].